2024 ATS Highlights

In this episode of Respiratory Exchange, Dr. Preethi Patel joins Dr. Daniel Culver to discuss preoperative pulmonary evaluation and its critical role in surgical outcomes. They explore why pulmonary complications are more common than cardiac events, key patient and procedural ris ...  Show more

Telomere biology disorders are increasingly recognized as drivers of pulmonary fibrosis, bone marrow failure, liver disease, and other age-related conditions. In this episode of Respiratory Exchange, Dr. Daniel Culver is joined by Dr. Brian Southern and Dr. Hetty Carraway to expl ...  Show more

JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.

Rela ...

APTA staff experts discuss highlights from the proposed 2024 Medicare Physician Fee Schedule: Cuts, but also potential good news around misvalued codes, PTA supervision, telehealth, and more. 

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Dr. Lillian Siu and Dr. Melvin Chua discuss the new technologies and novel therapeutics that were featured at the 2024 ASCO Breakthrough meeting.</span>

<span style= "text-decoration: underline; ...

For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ...  Show more